ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
Part of paid clinical trials in La Jolla, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT06128304
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 25 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- Core Implementation strategies — OTHERCore Implementation Strategies 1. Ongoing consultation 2. Educational meetings 3. Strengthen referral system 4. Prepare patients to be active participants
- Core+ Enhanced Implementation Strategies — OTHERIncludes all of the Core implementation strategies and adds: 5\. Community engagement using Health Beginning Initiative Model 6\. Smart Cards to facilitate patient engagement
Study Details
While there has been a significant increase in the uptake of antiretroviral therapy among women living with HIV (WLHIV) in many low- and-middle income countries (LMICs), the coverage of cervical cancer screening and treatment (CCST) among WLHIV remains low. This study aims to leverage the available infrastructure for HIV care and treatment programs in Nigeria to integrate cervical cancer screening and treatment and conduct a cluster randomized, hybrid type III trial design to assess the comparative effectiveness of a Core set of implementation strategies versus a Core+ (enhanced) set of implementation strategies to implement cervical cancer screening, onsite treatment, referral and referral completion, treatment, and retention in care among WLHIV. The overarching goal is to improve the health and life expectancy of WLHIV with co-occurring cervical cancer.
Key Dates
- Start date
- Nov 13, 2023
- Status verified
- Jan 2026
- Primary completion
- Dec 1, 2026
- Completion
- Aug 31, 2027
Study Design
- Enrollment
- 2,436 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Active Comparator: Core Implementation StrategiesCore Implementation Strategies 1. Ongoing consultation 2. Educational meetings 3. Strengthen referral system 4. Prepare patients to be active participants
- Experimental: Core+ Enhanced Implementation StrategiesIncludes all of the Core implementation strategies and adds: 5\. Community engagement using Health Beginning Initiative Model 6\. Smart Cards to facilitate patient engagement
Primary Outcome Measure
Reach [ Time Frame: 12 months after enrollment ]
Central Contacts
- Gregory Aarons, PhD858-966-7703
- Echezona Ezeanolue, MD, MPH+234 803 773 9972
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UC San Diego | La Jolla | California | 92093 |
Find similar trials in La Jolla, CA
Related Studies
- The Use of Leukapheresis to Support HIV Pathogenesis StudiesRecruiting · University of California, San Francisco · San Francisco, California
- The Use of Lymph Node Biopsies to Support HIV Pathogenesis StudiesRecruiting · University of California, San Francisco · San Francisco, California
- Collection of Blood for Multiple Collaborative StudiesRecruiting · University of California, San Francisco · San Francisco, California
- A Multicenter Cancer Biospecimen Collection StudyRecruiting · Cofactor Genomics, Inc. · San Francisco, California